Beyond Dimerization: A Membrane-dependent Activation Model for Interleukin-4 Receptor-mediated Signalling

Journal of Molecular Biology

Volumn 366, Issue 5, 2007, Pages 1365-1373

  Weidemann, Thomas ^a   Höfinger, Siegfried ^b   Müller, Kurt ^a   Auer, Manfred ^a  

^a Novartis Inst for Biomedical Res   (Austria)

^b MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

Author keywords

free energy perturbation; interleukin 4 receptor; membrane biophysics; signal transduction; WSXWS motif

Indexed keywords

AMINO ACID; CYTOKINE RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA;

ARTICLE; DIMERIZATION; ENERGY TRANSFER; LIPID BILAYER; MEMBRANE MODEL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SURFACE PROPERTY;

EID: 33846849303     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.095     Document Type: Article

References (55)

1. Kristensen D.M., Kalisz M., and Nielsen J.H. Cytokine signalling in embryonic stem cells. APMIS 113 (2005) 756-772
2. Horsley V., Jansen K.M., Mills S.T., and Pavlath G.K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113 (2003) 483-494
3. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2 (2002) 933-944
4. Kaushansky K. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354 (2006) 2034-2045
5. Kovanen P.E., and Leonard W.J. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202 (2004) 67-83
6. Touw I.P., De Koning J.P., Ward A.C., and Hermans M.H. Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol. Cell Endocrinol. 160 (2000) 1-9
7. Arkin M.R., and Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Rev. Drug Discov. 3 (2004) 301-317
8. Mueller T.D., Zhang J.L., Sebald W., and Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta 1592 (2002) 237-250
9. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
10. Fuh G., et al. Rational design of potent antagonists to the human growth hormone receptor. Science 256 (1992) 1677-1680
11. Cosman D. The hematopoietin receptor superfamily. Cytokine 5 (1993) 95-106
12. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 80 (1995) 213-223
13. Livnah O., et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283 (1999) 987-990
14. Remy I., Wilson I.A., and Michnick S.W. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283 (1999) 990-993
15. Livnah O., et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nature Struct. Biol. 5 (1998) 993-1004
16. Ballinger M.D., and Wells J.A. Will any dimer do?. Nature Struct. Biol. 5 (1998) 938-940
17. Constantinescu S.N., Huang L.J., Nam H., and Lodish H.F. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol. Cell 7 (2001) 377-385
18. Seubert N., et al. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol. Cell 12 (2003) 1239-1250
19. Jiang J., et al. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Mol. Endocrinol. 18 (2004) 2981-2996
20. Wan Y., McDevitt A., Shen B., Smythe M.L., and Waters M.J. Increased site 1 affinity improves biopotency of porcine growth hormone. Evidence against diffusion dependent receptor dimerization. J. Biol. Chem. 279 (2004) 44775-44784
21. Brown R.J., et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nature Struct. Mol. Biol. 12 (2005) 814-821
22. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 (1999) 701-738
23. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 253-262
24. Hershey G.K. IL-13 receptors and signaling pathways: an evolving web. J. Allergy Clin. Immunol. 111 (2003) 677-690
25. Andrews A.L., Holloway J.W., Puddicombe S.M., Holgate S.T., and Davies D.E. Kinetic analysis of the interleukin-13 receptor complex. J. Biol. Chem. 277 (2002) 46073-46078
26. Damjanovich S., et al. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc. Natl Acad. Sci. USA 94 (1997) 13134-13139
27. Vamosi G., et al. IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc. Natl. Acad. Sci. USA 101 (2004) 11082-11087
28. Rao R., Logan B., Forrest K., Roszman T.L., and Goebel J. Lipid rafts in cytokine signaling. Cytokine Growth Factor Rev. 15 (2004) 103-110
29. Fitzgerald K.A., O'Neill L.A.J., Gearing A.J.H., and Callard R.E. The Cytokine Facts Book (2001), Academic Press, London
30. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87 (1990) 6934-6938
31. Jiang H., Harris M.B., and Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105 (2000) 1063-1070
32. Yamaoka K., et al. The Janus kinases (Jaks). Genome Biol. 5 (2004) 253
33. Hofmann S.R., et al. Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited. Mol. Cell Biol. 24 (2004) 5039-5049
34. Hage T., Sebald W., and Reinemer P. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell 97 (1999) 271-281
35. Wang Y., Shen B.J., and Sebald W. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. Proc. Natl. Acad. Sci. USA 94 (1997) 1657-1662
36. Zhang J.L., Simeonowa I., Wang Y., and Sebald W. The high-affinity interaction of human IL-4 and the receptor alpha chain is constituted by two independent binding clusters. J. Mol. Biol. 315 (2002) 399-407
37. Livnah O., et al. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273 (1996) 464-471
38. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nature Struct. Biol. 3 (1996) 842-848
39. Reithmeier R.A. Characterization and modeling of membrane proteins using sequence analysis. Curr. Opin. Struct. Biol. 5 (1995) 491-500
40. White S.H., and Wimley W.C. Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 28 (1999) 319-365
41. Ulmschneider M.B., and Sansom M.S. Amino acid distributions in integral membrane protein structures. Biochim. Biophys. Acta 1512 (2001) 1-14
42. Chiu S.W., Subramaniam S., and Jakobsson E. Simulation study of a gramicidin/lipid bilayer system in excess water and lipid. I. Structure of the molecular complex. Biophys. J. 76 (1999) 1929-1938
43. Yau W.M., Wimley W.C., Gawrisch K., and White S.H. The preference of tryptophan for membrane interfaces. Biochemistry 37 (1998) 14713-14718
44. Liu W., and Caffrey M. Interactions of tryptophan, tryptophan peptides, and tryptophan alkyl esters at curved membrane interfaces. Biochemistry 45 (2006) 11713-11726
45. Simonson T., Archontis G., and Karplus M. Free energy simulations come of age: protein-ligand recognition. Accts Chem. Res. 35 (2002) 430-437
46. Hofinger S., and Zerbetto F. Simple models for hydrophobic hydration. Chem. Soc. Rev. 34 (2005) 1012-1020
47. Tomasi J., Mennucci B., and Cammi R. Quantum mechanical continuum solvation models. Chem. Rev. 105 (2005) 2999-3093
48. Baumgartner J.W., Wells C.A., Chen C.M., and Waters M.J. The role of the WSXWS equivalent motif in growth hormone receptor function. J. Biol. Chem. 269 (1994) 29094-29101
49. Doshi P.D., and DiPersio J.F. Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression. Blood 84 (1994) 2539-2553
50. Hilton D.J., Watowich S.S., Katz L., and Lodish H.F. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 271 (1996) 4699-4708
51. Miyazaki T., Maruyama M., Yamada G., Hatakeyama M., and Taniguchi T. The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J. 10 (1991) 3191-3197
52. Quelle D.E., Quelle F.W., and Wojchowski D.M. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization. Mol. Cell Biol. 12 (1992) 4553-4561
53. Ronco L.V., et al. Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J. Biol. Chem. 269 (1994) 277-283
54. Yoshimura A., et al. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. J. Biol. Chem. 267 (1992) 11619-11625
55. Hermanns H.M., Muller-Newen G., Heinrich P.C., and Haan S. Bow to your partner for signaling. Nature Struct. Mol. Biol. 12 (2005) 476-478